AgeX Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €48.23K -60.6% -€9.59M -24.7% -19,894.6% -95 pp -€14.74M +119.4% -30,562.5% -250 pp
    €122.29K +317.6% -€12.75M +38.7% -10,424.6% +210 pp -€6.72M +31.3% -5,493.0% +120 pp
    €29.28K -76.4% -€9.19M +4.4% -31,394.1% -240 pp -€5.11M -24.4% -17,467.6% -120 pp
    €124.01K -92.3% -€8.80M -6.9% -7,097.2% -65 pp -€6.76M +0.7% -5,454.9% -50 pp
    €1.61M +8.1% -€9.45M -11.4% -587.6% +1.3 pp -€6.71M -18.1% -417.4% +1.3 pp
    €1.49M +23.8% -€10.66M +65.1% -716.7% -1.8 pp -€8.20M +56.0% -550.9% -1.1 pp
    €1.20M -0.6% -€6.46M +14.0% -537.4% -0.69 pp -€5.25M -2.9% -437.1% +0.10 pp
    €1.21M -€5.67M -468.7% -€5.41M -447.6%

    Notifications